| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 3 |
| 1 | ADALIMUMAB | 2 |
| 2 | AMLODIPINE BESYLATE AND VALSARTAN | 2 |
| 3 | LENALIDOMIDE | 2 |
| 4 | VEDOLIZUMAB | 2 |
| 5 | ACETAMINOPHEN | 1 |
| 6 | ACETAMINOPHEN 500MG | 1 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 8 | AZATHIOPRINE | 1 |
| 9 | BISOPROLOL FUMARATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FILGRASTIM-SNDZ | 1 | 0.0003 |
| 1 | AMLODIPINE BESYLATE AND VALSARTAN | 2 | 0.0002 |
| 2 | TEDUGLUTIDE | 1 | 0.0001 |
| 3 | URSOSIOL | 1 | 0.0001 |
| 4 | MYCOPHENILIC ACID | 1 | 0.0000 |
| 5 | URSODIOL | 1 | 0.0000 |
| 6 | ORAL SEMAGLUTIDE | 3 | 0.0000 |
| 7 | OCTREOTIDE ACETATE | 1 | 0.0000 |
| 8 | MYCOPHENOLIC ACID | 1 | 0.0000 |
| 9 | CANDESARTAN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 2 | Bile Acid [EPC] | 1 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 4 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 8 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |